Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.500 | None | 0.974 | 6 | 0 | 1997 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.500 | None | 0.953 | 5 | 0 | 1995 | 2020 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
group | 0.500 | None | 0.964 | 1 | 0 | 1995 | 2020 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
group | 0.480 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.400 | None | 0.955 | 15 | 0 | 2000 | 2020 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.400 | None | 0.923 | 8 | 0 | 1996 | 2020 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
group | 0.400 | None | 0.986 | 7 | 0 | 1999 | 2020 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
group | 0.400 | None | 0.914 | 6 | 0 | 2002 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.400 | None | 0.956 | 6 | 0 | 1994 | 2020 | ||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 1994 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.400 | None | 0.976 | 2 | 0 | 1995 | 2020 | ||||||||
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2005 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.400 | None | 0.952 | 2 | 0 | 2003 | 2020 | ||||||||
|
growth hormone 1 | 0.373 | 0.923 | 3.0E-02 |
|
group | 0.400 | None | 0.923 | 2 | 0 | 2003 | 2019 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
group | 0.400 | None | 0.963 | 1 | 0 | 1997 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
group | 0.400 | None | 0.917 | 1 | 0 | 2002 | 2019 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2000 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.889 | 1 | 0 | 2004 | 2019 | ||||||||
|
cystathionine beta-synthase | 0.465 | 0.885 | 3.1E-05 |
|
group | 0.390 | None | 0.778 | 1 | 0 | 1996 | 2015 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
group | 0.390 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
selectin E | 0.447 | 0.808 | 7.9E-10 |
|
group | 0.390 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
proprotein convertase subtilisin/kexin type 9 | 0.482 | 0.808 | 2.7E-17 |
|
group | 0.200 | None | 0.963 | 1 | 0 | 2007 | 2020 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1995 | 2020 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1998 | 2019 |